• Home
  • WuXi STA
  • Highly potent API and ADC payload and payload-linker manufacturing

Highly potent API and ADC payload and payload-linker manufacturing

Highly potent API and ADC payload and payload-linker manufacturing
Product Description

WuXi STA's Jinshan site and WuXi STA's Changzhou site are equipped with a R&D labs, a cGMP HP Kilo lab, and cGMP plant for handling highly potent APIs (HPAPIs) and antibody drug conjugate (ADC) payloads and payload-linkers. We offer drug product manufacturing at STA’s Shanghai Waigaoqiao site and soon our Wuxi city site. These facilities offer containment level down to an OEL limit of 0.05 μg/m³. Our teams have the expertise and track records operating equipment under rigorous handling procedures for HPAPIs, ADC payloads and payload-linkers for global clients

Read more Show less

WuXi STA

  • US
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
View company profile
Categories
more categories Show less

WuXi STA

  • US
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
View company profile

More Products from WuXi STA (4)

  • Pre-formulation development

    Product Pre-formulation development

    WuXi STA's IND Enabling Preformulation Package (IEPP) is an integrated end-to-end developability assessment service for new chemical entities (NCE). Efficiently identify challenges and solutions earlier for higher success rates and lower overall costs. PK formulation, Profiling, Form selection, and&nb...
  • Bioavailability enhancement and advanced delivery technologies

    Product Bioavailability enhancement and advanced delivery technologies

    Bioavailability Toolbox:Spray-dried dispersion (SDD) - preclinical to commercial scale
    Hot melt extrusion (HME)
    Nano suspension
    Softgel & Liquid filled capsules
    Injectable
  • Peptide Process Development and Manufacturing

    Product Peptide Process Development and Manufacturing

    WuXi STA Peptide platform services include: Process R&D, Manufacturing grams to kilograms peptides under cGMP, Analytical characterization, method development and validation, IPC & release testing, ICH compliant stability studies, Regulatory (CMC) submission support. Our platform support a wide var...
  • Oligonucleotide Process Development and Manufacturing

    Product Oligonucleotide Process Development and Manufacturing

    WuXi STA has an integrated Oligo API process R&D and manufacturing platform from preclinical to commercial, operating at our US FDA inspected integrated process R&D and manufacturing facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modal...

WuXi STA resources (4)